Harrow Health Inc. 8.625% Senior Notes due 2026

Company Profile

Harrow Health Inc. 8.625% Senior Notes due 2026 had its IPO on 2021-05-07 under the ticker symbol HROWL.

The company operates in the sector and industry. Harrow Health Inc. 8.625% Senior Notes due 2026 has a staff strength of 0 employees.

Stock update

Shares of Harrow Health Inc. 8.625% Senior Notes due 2026 opened at $24.04 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $24 - $24.15, and closed at $24.01.

This is a -0.17% slip from the previous day's closing price.

A total volume of 2,767 shares were traded at the close of the day’s session.

In the last one week, shares of Harrow Health Inc. 8.625% Senior Notes due 2026 have slipped by -0.79%.

Harrow Health Inc. 8.625% Senior Notes due 2026's Key Ratios

Harrow Health Inc. 8.625% Senior Notes due 2026 has a market cap of $247.48 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Harrow Health Inc. 8.625% Senior Notes due 2026’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Harrow Health Inc. 8.625% Senior Notes due 2026's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Harrow Health Inc. 8.625% Senior Notes due 2026’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 44.84%.

In Q2, Harrow Health Inc. 8.625% Senior Notes due 2026’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Harrow Health Inc. 8.625% Senior Notes due 2026’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Harrow Health Inc. 8.625% Senior Notes due 2026’s profitability.

Harrow Health Inc. 8.625% Senior Notes due 2026 stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Harrow Health Inc. 8.625% Senior Notes due 2026 stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$223.99 million

Total Liabilities

$23.01 million

Operating Cash Flow

$-1249000.00

Capital Expenditure

$1.25 million

Dividend Payout Ratio

0%

Harrow Health Inc. 8.625% Senior Notes due 2026 ended 2024 with $223.99 million in total assets and $0 in total liabilities. Its intangible assets were valued at $223.99 million while shareholder equity stood at $22.05 million.

Harrow Health Inc. 8.625% Senior Notes due 2026 ended 2024 with $0 in deferred long-term liabilities, $23.01 million in other current liabilities, 30000.00 in common stock, $-120365000.00 in retained earnings and $332000.00 in goodwill. Its cash balance stood at $22.75 million and cash and short-term investments were $22.75 million. The company’s total short-term debt was $764,000 while long-term debt stood at $169.71 million.

Harrow Health Inc. 8.625% Senior Notes due 2026’s total current assets stands at $60.30 million while long-term investments were $0 and short-term investments were $6.92 million. Its net receivables were $18.26 million compared to accounts payable of $10.51 million and inventory worth $8.56 million.

In 2024, Harrow Health Inc. 8.625% Senior Notes due 2026's operating cash flow was $-1249000.00 while its capital expenditure stood at $1.25 million.

Comparatively, Harrow Health Inc. 8.625% Senior Notes due 2026 paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$24.01

52-Week High

$24.86

52-Week Low

$21.4484

Analyst Target Price

$

Harrow Health Inc. 8.625% Senior Notes due 2026 stock is currently trading at $24.01 per share. It touched a 52-week high of $24.86 and a 52-week low of $24.86. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $24.37 and 200-day moving average was $23.37 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.